Overview
This webinar presents a multidisciplinary tumor board format to explore the management of complex Stage III and IVa thymomas. It will address current gaps by offering expert consensus and practical take-home points based on available literature and clinical experience.
- Be comfortable to present a patient with stage III or IVa thymoma in a multidisciplinary tumor board.
- Determine the optimal treatment regimen for Stage III and IVa thymoma.
- Discuss future areas of study in the management of Stage III and IVa thymoma.
The IASLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
IASLC designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- Be comfortable to present a patient with stage III or IVa thymoma in a multidisciplinary tumor board.
- Determine the optimal treatment regimen for Stage III and IVa thymoma.
- Discuss future areas of study in the management of Stage III and IVa thymoma.
The IASLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
IASLC designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Share
Participants
MD, FACS
Kaiser Permanente Northern California
Nicolas Girard
MD
Head of Thoracic Oncology
Institut Curie
MD
MD Anderson
MD
Mayo Clinic
MD, DM
All India Institute of Medical Sciences
MD
Columbia University Medical Center
MD, PhD, DSC
The Institute of Tuberculosis and Lung Diseases
MC, MSc
Emory University School of Medicine
MD
New York Proton Center